Jikei-Evaluation of basal insulin analogue on (nocturnal) glycaemic variability with continuous glucose monitoring -existing basal insulin analogue versus Tresiba; insulin degludec - a new basal insulin analogue, in basal-bolus treatment in type 2 diabetes
Phase of Trial: Phase III
Latest Information Update: 27 Oct 2016
Price : $35 *
At a glance
- Drugs Insulin degludec (Primary) ; Insulins
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms JET-2
- 26 Oct 2016 Status changed from recruiting to completed.
- 29 Apr 2015 Planned End Date changed to 1 Jun 2015 according to University Hospital Medical Information Network - Japan record.
- 01 Jul 2014 New trial record